Patients with type 2 diabetes (T2D) and peripheral artery disease or diabetic foot ulcers who initiated semaglutide instead of other glucose-lowering medications had a significantly reduced risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results